DCM
TSVT

DAFNA Capital Management’s 2seventy bio TSVT Stock Holding History

DAFNA Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-429,252
Closed -$2.12M – 85
2025
Q1 		$2.12M Hold
429,252
– – 0.6% 35
2024
Q4 		$1.26M Sell
429,252
-200,777
-32% -$824K 0.32% 52
2024
Q3 		$2.97M Sell
630,029
-420,680
-40% -$1.9M 0.7% 34
2024
Q2 		$4.05M Sell
1,050,709
-153,342
-13% -$691K 0.97% 30
2024
Q1 		$6.44M Sell
1,204,051
-243,414
-17% -$1.14M 1.47% 23
2023
Q4 		$6.18M Hold
1,447,465
– – 1.48% 22
2023
Q3 		$5.67M Buy
1,447,465
+951,049
+192% +$6.24M 1.76% 17
2023
Q2 		$5.02M Buy
+496,416
New +$5.26M 1.37% 23

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

DAFNA Capital Management's TSVT Position: Q2 2025 in Review

DAFNA Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 429,252 shares — an estimated $2.12M sold.

DAFNA Capital Management first reported a position in TSVT in Q2 2023 and held it in 8 quarters. The position peaked at $6.44M in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • DAFNA Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • DAFNA Capital Management sold 429,252 2seventy bio shares in Q2 2025, an estimated $2.12M.
  • DAFNA Capital Management first reported a position in 2seventy bio in Q2 2023 and held it in 8 quarters.
  • DAFNA Capital Management's 2seventy bio position peaked at $6.44M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on DAFNA Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.